The coronavirus and its variants have held the world captive for months, with no end in sight. Pharmaceutical solutions have proven powerless to stop the spread of COVID, and people have grown weary of the ongoing mandates and lockdowns that are preventing them from pursuing meaningful lives.
Yet few people know about the power of nutrients, particularly nicotinamide adenine dinucleotide (NAD) — a powerful coenzyme that plays multiple roles in cellular metabolism — to combat COVID and other viral infections by boosting natural immunity.
New research highlights the importance of maintaining healthy NAD levels to resist viral infections and build strong natural immunity. NAD therapy via IV infusion can boost NAD levels to provide an extra layer of protection against COVID and other viral infections.
NAD, COVID and High-Risk Populations
NAD is present in every cell of the human body, and it plays a role in multiple metabolic pathways. It affects factors that regulate the aging process, and plays a key role in mitochondrial function and the production of ATP, the energy molecule. Low NAD levels have been directly associated with increased risk of hospitalization and mortality from Coronavirus.
Populations at the highest risk of death from COVID include:
- Octogenarians and elderly
- Morbidly obese
- Type II diabetics
- Hypertensive adults and those with heart disease
- Adults with chronic obstructive respiratory disease (COPD)
High-risk populations tend to have lower NAD levels than the general population. The body naturally generates NAD, but its production begins to drop as people age. Babies and young children typically have very high levels of NAD, while levels are substantially lower in the elderly.
In cases of obesity and metabolic disease, NAD levels are low in multiple organs and tissues, including adipose tissue, muscles, liver and the brain’s hypothalamus. Those conditions often promote low-grade chronic inflammation that negatively impacts vascular endothelial function.
Low NAD levels can inhibit the function of Silent Information Regulator 1 (SIRT1), an NAD-dependent signaling protein that plays a key role in obesity-related metabolic disease and helps to control inflammation
How NAD Combats Viral Infections
NAD plays a vital role in metabolism and immune response. Recent research from 2022 shows that Coronavirus depletes NAD levels in affected patients as an innate response to infection. When patients whose NAD levels are already depleted become infected with a virus, further depletion can be fatal.
SIRT1 works to control and modify the inflammatory response to viral infections. In the case of COVID, an uncontrolled release of pro-inflammatory cytokines — sometimes referred to as a cytokine storm — is often responsible for severe symptoms and death.
In order for SIRT1 to perform its inflammation-mediating function, ample levels of zinc are needed for the SIRT1 molecule to bind to NAD. In many cases, at-risk populations are zinc-deficient. When coupled with already-low NAD levels, zinc deficiency can be a key factor in the severity of symptoms and risk of death.
In addition to controlling and modifying the inflammatory response, SIRT1, along with other members of the sirtuin family, defends against RNA viral pathogens such as coronavirus. Coronaviruses are made up of three proteins, including the membrane protein, the envelope protein, and the spike protein.
The spike protein contained in mRNA gene therapy injections is engineered to rapidly replicate in the body’s tissues, and is thought to be responsible for myocarditis, reproductive issues and other serious side effects of mRNA treatment.
Without NAD and zinc, the capacity of sirtuins to combat inflammation, coronavirus, spike proteins, and other viral infections is severely compromised.
NAD IV Therapy as a Hedge Against COVID and Seasonal Viruses
High-risk individuals or anyone who wants to enhance their immune response to viral infections can benefit from NAD IV therapy. When delivered by IV infusion, NAD can quickly access depleted cells and bind with SIRT1 to fight infection.
The protective properties of NAD can be further enhanced when combined with an antiviral IV cocktail that contains zinc, high-dose Vitamin C and other vital nutrients that support the immune system. A newly released 2022 study shows that recovery from COVID 19 is significantly accelerated when patients are treated with zinc and high-dose Vitamin C via IV infusion.
Get Antiviral NAD IV Treatment in NYC
New York City has perhaps been hit hardest by the coronavirus, in part due to its dense population and cold winter climate. Resilient New Yorkers want effective solutions to combat viral infections, so they can go about their business and enjoy their lives.
Invita Cryo offers a broad range of IV nutrient cocktails, nutrient injection therapies and cryotherapy, all designed to help you maintain peak health and vitality. Contact Invita Cryo today, and schedule your NAD IV therapy session to boost your immune system and fight viral infections at the cellular level.
Schedule an Appointment Today
Brenner, Charles. “Viral infection as an NAD+ battlefield.” Nature Metabolism (2022): 1-2.
Miller, R., A. R. Wentzel, and G. A. Richards. “COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity.” Medical hypotheses 144 (2020): 110044.
Ried, Karin, Taufiq BinJemain, and Avni Sali. “Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial.” Cureus 13.11 (2021).